DataConnect Is Now Available Globally Across Six Major Digital Platforms
1.7.2021 12:48:00 EEST | Business Wire | Press release
DataConnect, the global initiative to enable viewing mixed-brand fleets in a single platform, is now live with an expanded line of six major digital platforms and available to farm operations around the world. Case IH, STEYR and New Holland now join John Deere, CLAAS and the European farm management platform 365FarmNet, which launched the feature late last fall.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210701005365/en/
DataConnect is a collaboration between CNH Industrial, John Deere, CLAAS and 365FarmNet to enable farms to view all their vehicles within a single digital platform of their choice. Illustration: DataConnect brands
Any farm operations using any self-propelled forage harvesters, combines or tractors from the participating brands now can view it all in one participating platform. Previously, viewing such information required managing additional portal for each brand involved.
With this new approach, customers can view five different machinery data parameters from their machine fleet:
- current machine location
- historical machine position
- fuel tank level
- status of the machine in the field
- machine speed
Any farm operator/owner who want to use the option simply needs to provide themselves with the permission to view all equipment in the platform that is most convenient for them. Once connected, the machines of the other manufactures appear automatically in that portal. The vehicles are even displayed with icons in the respective brand colors.
DataConnect works without any additional hardware and software components and ensures secure data handling. The solution will apply to hundreds of thousands of already connected machines.
The addition of CNH Industrial means that users of AFS Connect, the telematics platform of Case IH, MyPLM Connect for New Holland, and S-Tech for STEYR, will have the option for the cloud-to-cloud exchange of data with both John Deere Operations Center and CLAAS TELEMATICS or 365FarmNet portals.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210701005365/en/
Contact information
John Deere Walldorf GmbH & Co. KG, Impexstraße 3, 69190 Walldorf,
Ralf Lenge, phone: +49 171 4161599, e-mail: LengeRalf@JohnDeere.com
365FarmNet Group KGaA mbH & CoKG, Hausvogteiplatz 10, 10117 Berlin,
Yasmin Möhring, phone: +49 151 172 81 869 e-mail: moehring@365farmnet.com
CLAAS KGaA mbH, Mühlenwinkel 1, 33428 Harsewinkel,
Matthias Mumme, phone: +49 5247/12-2288, e-mail: matthias.mumme@claas.com
CNH Industrial, United States
Dan Danford, phone: +1 (262) 321-8856, e-mail: dan.danford@cnhind.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 13:00:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 13:00:00 EEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 12:15:00 EEST | Press release
HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612936893/en/ HUI (HUI:VSE) merges traditional and crypto finance: commences continuous trading in Vienna with leading market maker and announces impending token listing on major global exchange Emmanuelle Deba
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 10:35:00 EEST | Press release
India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 10:00:00 EEST | Press release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom